CLASS II Device recall · Reported 28 Sep 2022 · FDA Enforcement Report

The Randox Serology I Positive Control contains recalled

Randox Laboratories is recalling The Randox Serology I Positive Control contains the following analytes in human based, distributed nationwide in the US. The recall was initiated on 1 Aug 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesGTIN: 05055273216509 Lot number: 036SR Exp Date: 28th March 2023
Quantity recalled2 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1772-2022
FDA event ID
90777
Recalling firm
Randox Laboratories, Crumlin (North), N/A
Classification
Class II
Status
Terminated
Recall initiated
1 Aug 2022
FDA classified
19 Sep 2022
Reported
28 Sep 2022
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

1 Aug 2022Recall initiated by company
19 Sep 2022Classified by FDA+49 days
28 Sep 2022Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

***Update** :HBsAg analyte is also Non-Reactive on the Ortho Vitros analyser as well as the Beckman Coulter DxI. Randox Serology I Positive Control will test negative (Non-Reactive) for Marker HBsAg resulting in delay in reporting patient results due to the positive control O36SR testing negative (Non-Reactive) for Marker HBsAg

Product as listed by the FDA

The Randox Serology I Positive Control contains the following analytes in human based plasma: Anti HIV 1/2, Anti HTLV 1/2, Anti HCV, HBsAg, Anti HBc, and Anti Treponema pallidum IgG. The product is delivered as a liquid in a kit of 3 identical ready-to-use vials of 5 mL each.

Where it was distributed

US Nationwide distribution in the states of WV, NC.

Nationwide North CarolinaWest Virginia

Questions about this recall

Is The Randox Serology I Positive Control contains the following analytes in human based recalled?

Yes. Randox Laboratories recalled The Randox Serology I Positive Control contains the following analytes in human based on 1 Aug 2022. The recall is Class II and its status is Terminated. Recall number Z-1772-2022.

Why was it recalled?

***Update** :HBsAg analyte is also Non-Reactive on the Ortho Vitros analyser as well as the Beckman Coulter DxI. Randox Serology I Positive Control will test negative (Non-Reactive) for Marker HBsAg resulting in delay in reporting patient results due to the positive control O36SR testing negative (Non-Reactive) for Marker HBsAg

Which lots are affected?

GTIN: 05055273216509 Lot number: 036SR Exp Date: 28th March 2023

Where was it sold?

US Nationwide distribution in the states of WV, NC.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Randox Laboratories

All 98

Other Other Medical Devices recalls

All 13,778